Tag: Abingworth

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Abingworth

Sientra Q2 2018 Big Money Sentiment Better Than Expected, now at 3.75

Added to Collection on: 2018-11-06 23:22:30

Tags for this article:

Finance
Economy
NASDAQ
Short
Economy of New York City
Investment
Abingworth

Click the tags to see associated articles and topics

View Article Details
Abingworth raises $582m for late-stage fund ACCD 2

Added to Collection on: 2021-05-10 09:33:45

Tags for this article:

Companies
Life Sciences
Abingworth
AstraZeneca
IQVIA
Industry economics)

Click the tags to see associated articles and topics

View Article Details
Abingworth taps biopharma's appetite for risk-sharing

Added to Collection on: 2021-05-13 14:26:15

Tags for this article:

Finance
Money
Economy
Corporate finance
Equity securities
Venture capital
Entrepreneurship
Private equity
Abingworth
Thakeham
Tim Haines

Click the tags to see associated articles and topics

View Article Details
Vera Therapeutics Makes Its Debut After Others Delay IPOs

Added to Collection on: 2021-05-14 15:11:15

Tags for this article:

Initial public offering
Finance
Sofinnova
Investment
Abingworth
Prospectus
Evercore
Vera Security
Financial markets

Click the tags to see associated articles and topics

View Article Details
Biopharma and venture capital: a deep dive

Added to Collection on: 2021-06-03 14:15:00

Tags for this article:

Finance
Sofinnova
Money
Investment
Venture capital
Abingworth

Click the tags to see associated articles and topics

View Article Details
A cancer drug startup banks new funds for NK cell therapy

Added to Collection on: 2021-07-15 16:07:30

Tags for this article:

Branches of biology
Medical specialties
Immune system
Clinical medicine
Natural killer cell
Chimeric antigen receptor T cell
Abingworth
Leukemia
T cell
ALLO-715

Click the tags to see associated articles and topics

View Article Details
CymaBay secures $100M to bankroll phase 3 development of resurrected liver drug

Added to Collection on: 2021-08-02 15:45:00

Tags for this article:

Medical specialties
Clinical medicine
Hepatology
Autoimmune diseases
Hepatitis
Primary biliary cholangitis
Orphan drugs
Primary sclerosing cholangitis
Non-alcoholic fatty liver disease
Liver
Steatohepatitis
Obeticholic acid
Abingworth

Click the tags to see associated articles and topics

View Article Details
HilleVax Closes $135 Million Crossover Financing to Advance Clinical Stage Norovirus ...

Added to Collection on: 2021-09-08 12:00:00

Tags for this article:

Medical specialties
Health care
Health
Vaccination
Maurice Hilleman
Measles
Mumps
Julie Gerberding
Merck & Co.
Norovirus
Hilleman Laboratories
Gavi
RA Capital Management
Jaime Sepulveda
Qiming Venture Partners
Greenspring Associates
Susan Silbermann
Deerfield Management Company
Frazier Healthcare Partners
Jeri Hilleman
BVF PARTNERS LP
Abingworth
HilleVax Inc.
Rajeev Venkayya
Franklin Templeton
Lightspeed Venture Partners

Click the tags to see associated articles and topics

View Article Details